We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for exporting nuclear equipment, material and technology that appears on what is known as the 'Trigger List'.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Explains how victims of persistent antisocial behaviour have the right to request a case review where a local threshold is met.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
This report look at ‘triggers’ that should be used to scale up in advance of new shocks of chronic crisis or vulnerability
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Report highlighting the lessons identified by the trial areas which is intended to be used by agencies for their own community trigger procedures
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Comply with good pharmacovigilance practice and prepare for an inspection.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
The symptoms, diagnosis, management, surveillance and epidemiology of Legionnaires' disease.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.